These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15152956)

  • 21. Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause.
    Segal S; Harvie HS; Siegelman E; Arya LA
    Menopause; 2011 Mar; 18(3):333-5. PubMed ID: 21301374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.
    Rees M; Pérez-López FR; Ceasu I; Depypere H; Erel T; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; van der Schouw Y; Tremollieres F;
    Maturitas; 2012 Oct; 73(2):171-4. PubMed ID: 22818886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvovaginal Atrophy.
    Kellogg-Spadt S
    Adv Nurse Pract; 2010 Apr; 18(4):31-32, 34, 55. PubMed ID: 20486301
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaginal atrophy. Treatment options.
    Mayo Clin Health Lett; 2014 Nov; 32(11):7. PubMed ID: 26027044
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis.
    Kingsberg SA; Krychman ML
    J Sex Med; 2013 Jun; 10(6):1567-74. PubMed ID: 23534861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Not time to abandon use of local vaginal hormone therapies.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
    [No Abstract]   [Full Text] [Related]  

  • 28. The first published randomised controlled trial of laser treatment for vaginal atrophy raises serious questions.
    Buttini MJ; Maher C
    Med J Aust; 2018 Nov; 209(9):376-377. PubMed ID: 30376654
    [No Abstract]   [Full Text] [Related]  

  • 29. Atrophic vaginitis. Estrogen can help.
    Mayo Clin Health Lett; 2001 Jan; 19(1):6. PubMed ID: 11201532
    [No Abstract]   [Full Text] [Related]  

  • 30. The therapeutic role of estrogens in postmenopausal women.
    Freeman R; Lewis RM
    Endocrinol Metab Clin North Am; 2004 Dec; 33(4):771-89. PubMed ID: 15501645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing urogenital atrophy.
    Palacios S
    Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen for vulvovaginal symptoms: how low can you go?
    Brzezinski A; Benshushan A
    Menopause; 2009; 16(5):848-50. PubMed ID: 19564805
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogen therapy in atrophic vaginitis.
    Kyriazis GA; Balin H
    Pa Med; 1970 Dec; 73(12):32-4. PubMed ID: 5480497
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. By the way, doctor. My gynecologist says that I have atrophic vaginitis and that it's a common problem for menopausal women. In all my reading about menopause, I've never come across this condition. What can you tell me about it?
    Harv Womens Health Watch; 2002 Feb; 9(6):7. PubMed ID: 14521132
    [No Abstract]   [Full Text] [Related]  

  • 37. The sexual health benefits of oral low-dose estrogen plus progestogen and vaginal estrogen for postmenopausal women.
    Kingsberg SA
    Menopause; 2009; 16(2):224-5. PubMed ID: 19188846
    [No Abstract]   [Full Text] [Related]  

  • 38. Vulvovaginal atrophy: a common--and commonly overlooked--problem.
    Hohenhaus MH
    Med Health R I; 2011 May; 94(5):138-40. PubMed ID: 21710922
    [No Abstract]   [Full Text] [Related]  

  • 39. I stopped taking oral estrogen pills, and now vaginal dryness is a problem. My doctor suggested I use a vaginal cream containing estrogen. Is estrogen given this way absorbed by the body?
    Mayo Clin Health Lett; 2003 Aug; 21(8):8. PubMed ID: 12971311
    [No Abstract]   [Full Text] [Related]  

  • 40. Atrophic vaginitis treated with nitrofurazone-estrogen vaginal suppositories.
    Kearns PR; Stewart RH; Mendel EB
    J La State Med Soc; 1968 Nov; 120(11):457-60. PubMed ID: 5727825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.